DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Motzer RJ. et al.
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma.
N Engl J Med 2015;
373: 1803-1813
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.